Jiangsu Yuyue Medical Equipment & Supply Future Growth
Future criteria checks 2/6
Jiangsu Yuyue Medical Equipment & Supply is forecast to grow earnings and revenue by 6.5% and 16.9% per annum respectively. EPS is expected to grow by 6.2% per annum. Return on equity is forecast to be 16.5% in 3 years.
Key information
6.5%
Earnings growth rate
6.2%
EPS growth rate
| Medical Equipment earnings growth | 23.9% |
| Revenue growth rate | 16.9% |
| Future return on equity | 16.5% |
| Analyst coverage | Good |
| Last updated | 29 Apr 2024 |
Recent future growth updates
Recent updates
Earnings Report: Jiangsu Yuyue Medical Equipment & Supply Co., Ltd. Missed Revenue Estimates By 7.0%
Apr 30
The Return Trends At Jiangsu Yuyue Medical Equipment & Supply (SZSE:002223) Look Promising
Apr 22Jiangsu Yuyue Medical Equipment & Supply Co., Ltd.'s (SZSE:002223) Shares Lagging The Market But So Is The Business
Apr 03Earnings and Revenue Growth Forecasts
| Date | Revenue | Earnings | Free Cash Flow | Cash from Op | Avg. No. Analysts |
|---|---|---|---|---|---|
| 12/31/2026 | 11,197 | 2,935 | N/A | 2,605 | 1 |
| 12/31/2025 | 10,518 | 2,549 | N/A | 2,456 | 8 |
| 12/31/2024 | 8,719 | 2,105 | N/A | 2,175 | 2 |
| 3/31/2024 | 7,500 | 2,342 | 1,875 | 1,987 | N/A |
| 12/31/2023 | 7,972 | 2,396 | 1,994 | 2,127 | N/A |
| 9/30/2023 | 8,648 | 2,650 | 2,602 | 2,885 | N/A |
| 3/31/2023 | 7,983 | 1,845 | 2,335 | 2,708 | N/A |
| 1/1/2023 | 7,102 | 1,595 | 1,926 | 2,305 | N/A |
| 9/30/2022 | 6,700 | 1,266 | 1,121 | 1,280 | N/A |
| 6/30/2022 | 6,854 | 1,307 | 1,224 | 1,328 | N/A |
| 3/31/2022 | 7,054 | 1,487 | 1,297 | 1,441 | N/A |
| 1/1/2022 | 6,894 | 1,482 | 917 | 1,201 | N/A |
| 9/30/2021 | 7,188 | 1,600 | 578 | 1,365 | N/A |
| 6/30/2021 | 6,898 | 1,603 | 491 | 1,255 | N/A |
| 3/31/2021 | 6,996 | 1,836 | 1,379 | 2,053 | N/A |
| 12/31/2020 | 6,726 | 1,759 | 2,152 | 2,831 | N/A |
| 9/30/2020 | 5,928 | 1,550 | 2,770 | 3,033 | N/A |
| 6/30/2020 | 5,555 | 1,339 | 2,574 | 2,859 | N/A |
| 3/31/2020 | 4,826 | 889 | 1,230 | 1,684 | N/A |
| 12/31/2019 | 4,636 | 753 | 174 | 614 | N/A |
| 9/30/2019 | 4,559 | 812 | 128 | 559 | N/A |
| 6/30/2019 | 4,462 | 791 | 219 | 732 | N/A |
| 3/31/2019 | 4,343 | 760 | 176 | 653 | N/A |
| 12/31/2018 | 4,183 | 727 | 409 | 798 | N/A |
| 9/30/2018 | 4,029 | 693 | 70 | 525 | N/A |
| 6/30/2018 | 3,903 | 664 | -92 | 374 | N/A |
| 3/31/2018 | 3,681 | 620 | -252 | 265 | N/A |
| 12/31/2017 | 3,542 | 592 | N/A | 242 | N/A |
| 9/30/2017 | 3,333 | 595 | N/A | 355 | N/A |
| 6/30/2017 | 3,073 | 567 | N/A | 455 | N/A |
| 3/31/2017 | 2,808 | 544 | N/A | 463 | N/A |
| 12/31/2016 | 2,640 | 500 | N/A | 674 | N/A |
| 9/30/2016 | 2,470 | 464 | N/A | 657 | N/A |
| 6/30/2016 | 2,440 | 444 | N/A | 632 | N/A |
| 3/31/2016 | 2,295 | 398 | N/A | 659 | N/A |
| 12/31/2015 | 2,104 | 364 | N/A | 543 | N/A |
| 9/30/2015 | 1,951 | 377 | N/A | 440 | N/A |
| 6/30/2015 | 1,838 | 357 | N/A | 338 | N/A |
| 3/31/2015 | 1,754 | 311 | N/A | 272 | N/A |
| 12/31/2014 | 1,682 | 297 | N/A | 206 | N/A |
| 9/30/2014 | 1,658 | 300 | N/A | 144 | N/A |
| 6/30/2014 | 1,614 | 294 | N/A | 123 | N/A |
| 3/31/2014 | 1,526 | 276 | N/A | 139 | N/A |
| 12/31/2013 | 1,424 | 258 | N/A | 124 | N/A |
| 9/30/2013 | 1,440 | 265 | N/A | 116 | N/A |
| 6/30/2013 | 1,383 | 264 | N/A | 222 | N/A |
Analyst Future Growth Forecasts
Earnings vs Savings Rate: 002223's forecast earnings growth (6.5% per year) is above the savings rate (2.9%).
Earnings vs Market: 002223's earnings (6.5% per year) are forecast to grow slower than the CN market (24.3% per year).
High Growth Earnings: 002223's earnings are forecast to grow, but not significantly.
Revenue vs Market: 002223's revenue (16.9% per year) is forecast to grow faster than the CN market (14.6% per year).
High Growth Revenue: 002223's revenue (16.9% per year) is forecast to grow slower than 20% per year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: 002223's Return on Equity is forecast to be low in 3 years time (16.5%).